We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
(-17%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$364M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$155M |
| 3 |
Textron
TXT
|
+$103M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$102M |
| 5 |
Sanofi
SNY
|
+$96.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$333M |
| 2 |
ExxonMobil
XOM
|
+$242M |
| 3 |
Dollar Tree
DLTR
|
+$231M |
| 4 |
Nutrien
NTR
|
+$213M |
| 5 |
National Vision
EYE
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.53% |
| 2 | Healthcare | 17.73% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Aon
AON
$76.5B
| $46.2M | 0.11% |
+171,169
| New | +$49.2M |
|
202
Entergy
ETR
$50.2B
| $45.8M | 0.11% |
813,604
-256,200
| -24% | -$15.1M |
|
203
Archer Daniels Midland
ADM
$38.2B
| $45.5M | 0.1% |
585,992
+1,700
| +0.3% | +$149K |
|
204
Synopsys
SNPS
$74.4B
| $45.4M | 0.1% |
149,400
-5,800
| -4% | -$1.75M |
|
205
Sysco
SYY
$40.8B
| $44.9M | 0.1% |
530,624
+139,700
| +36% | +$11.7M |
|
206
NXP Semiconductors
NXPI
$57.8B
| $44.9M | 0.1% |
303,408
+55,700
| +22% | +$9.68M |
|
207
United Rentals
URI
$67.2B
| $44.3M | 0.1% |
182,487
+61,743
| +51% | +$18.2M |
|
208
Freeport-McMoran
FCX
$90B
| $44.2M | 0.1% |
+1,509,300
| New | +$60.4M |
|
|
CHNG
209
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $44M | 0.1% |
+1,907,324
| New | +$44.6M |
|
210
TSMC
TSM
$2.1T
| $43M | 0.1% |
+526,000
| New | +$48.6M |
|
211
First Horizon
FHN
$12.2B
| $43M | 0.1% |
1,966,718
+366,718
| +23% | +$8.24M |
|
212
Aptiv
APTV
$12B
| $43M | 0.1% |
482,200
+199,700
| +71% | +$20.4M |
|
213
IQVIA
IQV
$38.7B
| $42.8M | 0.1% |
197,100
-2,400
| -1% | -$521K |
|
214
Realty Income
O
$59.6B
| $42.8M | 0.1% |
626,500
-264,300
| -30% | -$18.2M |
|
215
SM Energy
SM
$7.8B
| $42.7M | 0.1% |
+1,250,000
| New | +$50.8M |
|
|
CINC
216
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $42.7M | 0.1% |
2,265,461
+176,448
| +8% | +$3.38M |
|
217
Capital One
COF
$128B
| $42.7M | 0.1% |
409,474
+300
| +0.1% | +$36.7K |
|
218
Antero Resources
AR
$11.1B
| $42.3M | 0.1% |
1,380,000
-600,000
| -30% | -$21.9M |
|
219
Allegro MicroSystems
ALGM
$7.73B
| $42.2M | 0.1% |
2,039,696
+459,000
| +29% | +$11M |
|
220
KLA
KLAC
$239B
| $42.1M | 0.1% |
1,319,700
-169,000
| -11% | -$5.68M |
|
|
ESMT
221
DELISTED
EngageSmart, Inc.
ESMT
| $42M | 0.1% |
2,611,732
+457,017
| +21% | +$9.08M |
|
222
Take-Two Interactive
TTWO
$45.4B
| $41.8M | 0.1% |
341,521
+254,711
| +293% | +$32.4M |
|
223
Eaton
ETN
$161B
| $41.8M | 0.1% |
331,798
+5,300
| +2% | +$741K |
|
224
Northrop Grumman
NOC
$77.1B
| $41.7M | 0.1% |
87,073
-65,606
| -43% | -$30.1M |
|
|
LSXMK
225
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $41.6M | 0.1% |
1,491,105
+458,305
| +44% | +$14.5M |
|
Similar funds
Adage Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.
- Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
- Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
- Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
- Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
- Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
- Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
- Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.
Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.